Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Gliomas and Meningiomas – Risk Factors (Continued)

Chapter 1 - Epidemiology, Pathogenesis and Risk Factors of Brain Tumours

Across countries and populations, the incidence of brain tumours is related to gender, with opposite patterns for meningiomas and gliomas. The male/female ratio for meningioma is approximately 0.4 (1 man for 2.5 women).

This difference suggests that sex hormones and/or genetic differences between males and females may play a role in the occurrence of these tumours.

Hormonal receptors were identified in meningioma tissues: ≈80% of meningiomas have progesterone receptors, 40% oestrogen receptors and 40% androgen receptors.

Menopausal hormone therapy is associated with an increased meningioma risk. A recent meta-analysis suggests an increased risk in users of oestrogen-only hormone therapy.

Oral contraception and breast-feeding do not appear to increase the risk of meningioma.

To date, among exogenous suspected factors (electromagnetic fields, nutrition, pesticides, etc.), the only established causal link with risk of meningioma is high doses of ionising radiation.

Increased risk of meningioma is observed in rare hereditary syndromes, mainly neurofibromatosis Type 1 and 2 (NF1 and NF2), and possibly in Turner’s syndrome and Werner’s syndrome.

Germline and somatic mutations in meningiomas: a significant increase in risk of meningiomas is associated with neurofibromatosis Type 2 disease through mutation of the NF2 gene, and approximately 5% of individuals with schwannomatosis develop meningiomas, through mutation of the SWI/SNF chromatin remodeling complex subunit, SMARCB1.

Revision Questions

  1. Which primary CNS tumour has the lowest sex ratio (male/female)?
  2.  It is recommended to prescribe hormone therapy to menopausal women with meningioma. True or false?
  3. What are the two main histological types of primary CNS tumour associated with NF2 gene mutation?
Gliomas and Meningiomas – Risk Factors Summary and Further Reading

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.